The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
To compare The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy.
Epistemonikos ID: a1114a50f6d755c6a8db3933995e85b84d271d91
First added on: May 20, 2024